Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer with BRAF V600Em

Thyroid

Thyroid
III
Choe, Jennifer
NCT06475989
ECOGHNEA3231

Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) versus Fractionated SRS (FSRS) for Intact Brain Metastases

Not Available
III
Cmelak, Anthony
NCT06500455
NRGNEUBN013


A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

Neuro-Oncology

Neuro-Oncology
II
Mohler, Alexander
NCT05425004
VICC-ITNEU23261

A Phase 1, Open-Label, Multicenter Study of INCB160058 in Participants With Myeloproliferative Neoplasms

Not Available
I
Kishtagari, Ashwin
NCT06313593
VICC-DTHEM24055P

Phase Ib Study of Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

Multiple Cancer Types

Leukemia, Myelodysplastic Syndrome, Phase I
I
Ball, Somedeb
NCT06399640
VICC-VCHEM23008P


An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Multiple Cancer Types

Neuroblastoma (Pediatrics), Pediatric Solid Tumors
N/A
Kitko, Carrie
NCT01590680
VICCPED1249


Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Patients with Multiple Myeloma

Multiple Myeloma

Multiple Myeloma
N/A
Oluwole, Olalekan
NCT05346835
VICC-XDCTT24033

Clinical Trials Search CTA Inline Referral Form

To learn more about any of our clinical
trials, call 615-936-8422.